Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayuko Moriyama

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Immunological Medicine|January 11, 2025
Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS studyChie Ogita, Kazuteru Noguchi, Jiro Takeuchi, et al.
Modern Rheumatology|February 19, 2026
Effectiveness and safety of rituximab for remission maintenance therapy in microscopic polyangiitis and granulomatosis with polyangiitis in Japan: A retrospective multicenter cohort study (J-CANVAS)Motoki Takeuchi, Yoshiyuki Abe, Ayako Makiyama, et al.
Modern Rheumatology|January 31, 2025
Risk Factors for Cytomegalovirus Reactivation during the Treatment of ANCA-Associated Vasculitis: A retrospective cohort study of the J-CANVAS studyKazutaka Kawamori, Nao Oguro, Kunika Shimizu, et al.
Rheumatology (Oxford, England)|March 24, 2023
Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS studySatoshi Omura, Takashi Kida, Hisashi Noma, et al.
Clinical and Experimental Rheumatology|November 13, 2025
Modification of 2022 ACR/EULAR ANCA-associated vasculitis classification criteria in a Japanese cohort (J-CANVAS)Nakako Tanaka-Mabuchi, Takashi Kida, Shunichiro Hanai, et al.
Arthritis Research & Therapy|August 23, 2022
Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS)Yasuhiro Shimojima, Dai Kishida, Takanori Ichikawa, et al.
Modern Rheumatology|October 10, 2025
Real-world effectiveness of rituximab or intravenous cyclophosphamide versus non-use in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study of J-CANVASSatoshi Omura, Takashi Kida, Junya Kitai, et al.
Rheumatology International|November 12, 2025
Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS)Genki Kidoguchi, Yusuke Yoshida, Satoshi Omura, et al.
Clinical Rheumatology|August 12, 2024
Effectiveness and safety of rituximab in severely relapsed antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective analysis of a Japanese multicentre cohort from the J-CANVASGenki Kidoguchi, Yusuke Yoshida, Hirofumi Watanabe, et al.
International Journal of Rheumatic Diseases|February 11, 2026
Association Between Bronchiectasis and Serious Infections in Microscopic Polyangiitis and Granulomatosis With Polyangiitis From the J-CANVASSatoshi Omura, Takashi Kida, Hironori Inoue, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Immunological Medicine|January 11, 2025
Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS studyChie Ogita, Kazuteru Noguchi, Jiro Takeuchi, et al.
Modern Rheumatology|February 19, 2026
Effectiveness and safety of rituximab for remission maintenance therapy in microscopic polyangiitis and granulomatosis with polyangiitis in Japan: A retrospective multicenter cohort study (J-CANVAS)Motoki Takeuchi, Yoshiyuki Abe, Ayako Makiyama, et al.
Modern Rheumatology|January 31, 2025
Risk Factors for Cytomegalovirus Reactivation during the Treatment of ANCA-Associated Vasculitis: A retrospective cohort study of the J-CANVAS studyKazutaka Kawamori, Nao Oguro, Kunika Shimizu, et al.
Rheumatology (Oxford, England)|March 24, 2023
Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS studySatoshi Omura, Takashi Kida, Hisashi Noma, et al.
Clinical and Experimental Rheumatology|November 13, 2025
Modification of 2022 ACR/EULAR ANCA-associated vasculitis classification criteria in a Japanese cohort (J-CANVAS)Nakako Tanaka-Mabuchi, Takashi Kida, Shunichiro Hanai, et al.
Arthritis Research & Therapy|August 23, 2022
Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS)Yasuhiro Shimojima, Dai Kishida, Takanori Ichikawa, et al.
Modern Rheumatology|October 10, 2025
Real-world effectiveness of rituximab or intravenous cyclophosphamide versus non-use in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study of J-CANVASSatoshi Omura, Takashi Kida, Junya Kitai, et al.
Rheumatology International|November 12, 2025
Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS)Genki Kidoguchi, Yusuke Yoshida, Satoshi Omura, et al.
Clinical Rheumatology|August 12, 2024
Effectiveness and safety of rituximab in severely relapsed antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective analysis of a Japanese multicentre cohort from the J-CANVASGenki Kidoguchi, Yusuke Yoshida, Hirofumi Watanabe, et al.
International Journal of Rheumatic Diseases|February 11, 2026
Association Between Bronchiectasis and Serious Infections in Microscopic Polyangiitis and Granulomatosis With Polyangiitis From the J-CANVASSatoshi Omura, Takashi Kida, Hironori Inoue, et al.
Pageof 3